Immunomedics, Inc. Announces Conference Call and Webcast for Fourth Quarter and Fiscal Year 2012 Financial Results

MORRIS PLAINS, N.J., Aug. 10, 2012 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that it will host a conference call and live audio webcast on Friday, August 24, 2012 at 10:00 a.m. Eastern Time to discuss financial results for the fourth quarter and fiscal year 2012, and review key clinical developments and future planned activities.